SpyBiotech
Phase 1SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and chronic diseases.
Founded
2017
Focus
VaccinesViral Technology
About
SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and chronic diseases.
Funding History
2Total raised: $36.5M
Series A$32.5MF-Prime CapitalMar 15, 2021
Seed$4MOxford Sciences InnovationMay 15, 2018
Company Info
TypePrivate
Founded2017
LocationOxford, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile